[{"id":"1afa5b67-0ab9-48e8-b708-cf6daee5469f","acronym":"","url":"https://clinicaltrials.gov/study/NCT06034860","created_at":"2023-09-13T14:09:53.369Z","updated_at":"2024-07-02T16:35:06.666Z","phase":"Phase 1","brief_title":"Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types","source_id_and_acronym":"NCT06034860","lead_sponsor":"Molecular Templates, Inc.","biomarkers":" PD-L1 • MSI • PD-1","pipe":" | ","alterations":" MSI-H/dMMR","tags":["PD-L1 • MSI • PD-1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Opdivo (nivolumab) • MT-8421"],"overall_status":"Recruiting","enrollment":" Enrollment 200","initiation":"Initiation: 11/01/2023","start_date":" 11/01/2023","primary_txt":" Primary completion: 07/01/2026","primary_completion_date":" 07/01/2026","study_txt":" Completion: 10/01/2026","study_completion_date":" 10/01/2026","last_update_posted":"2024-05-01"}]